CancerFind
Blood-based multi-cancer early detection assay using methylation, copy-number and fragmentomic features.
- Developer
- IMBdx
- Intended use
- Multi Cancer Screening
- Cancer scope
- Bladder cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial cancer, Kidney cancer, Liver cancer, Lung cancer, Ovarian cancer, Pancreatic cancer, Prostate cancer, Stomach cancer
- Specimen
- Peripheral whole blood
- Molecular modality
- Copy number, DNA methylation, Fragmentomics
- Current version
- Current 12-cancer CancerFind blood-based MCED configuration after official 2025-12 expansion from 8 to 12 solid cancers
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.